| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.051 | 0.09 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.047 | 0.09 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |